BIND Therapeutics
A nanomedicine company that develops Accurins for targeted therapeutics
6
Funding Rounds
$69.9m
Money raised
Overview
A nanomedicine company that develops Accurins for targeted therapeutics
-
Website:
- Business model: B2B
- Headquarters: Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| No**** Af**** | - | - | |
| Ro**** La**** | - | - |
Industries
BIND Therapeutics is active in the following industries: